WANG, CHAU ZEN,王昭仁,王昭仁,CHEN, CHUNG HWAN,陈崇桓,陳崇桓,CHOU, LIANG YIN,周亮吟,周亮吟,CHOU, YU,周妤,周妤,HO, MEI LING,何美泠,何美泠,LIN, YI HSIUNG,林逸翔,林逸翔
申请号:
TW107109902
公开号:
TWI676482B
申请日:
2018.03.22
申请国别(地区):
TW
年份:
2019
代理人:
摘要:
The present invention involves a use of discoidin domain receptor 1 (DDR1) inhibitor for the manufacture of a medicament for preventing or treating osteoarthritis diseases. The present invention further involves a use of DDR1 activator for the manufacture of a medicament for preventing or treating achondroplasia-associated diseases.本發明涉及一種盤基蛋白結構域受體1(DDR1)抑制劑之用途,其係用於製備預防或治療骨關節炎之藥物。本發明還涉及一種DDR1活化劑之用途,其係用於製備預防或治療軟骨內骨化異常相關病症之藥物。